Clinical trial
Integrated Treatment for Cocaine and Mood Disorders - 1
NCT00227812 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00227812 |
|---|---|
| Title | Integrated Treatment for Cocaine and Mood Disorders - 1 |
| Official title | ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence, Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | Bupropion |
| Enrollment | 140 |
| Start date | Apr 1, 2001 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 28, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: